This compound is a nucleoside phosphoramidite building block used primarily in pharmaceutical and biotechnology research. It features a complex, highly modified nucleoside structure with multiple aromatic rings and a phosphoramidite group.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1391913-24-8
DMT-2'-O-TBDMS-G(dmf)-CE-phosphoramidite
nucleoside phosphoramidite for oligonucleotide synthesis
DMF-dG Phosphoramidite
nucleoside phosphoramidite building block
N'-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenyl-methoxy]methyl]-4-[2-cyanoethoxy-(diisopropylamino)phosphanyl]oxy-tetrahydrofuran-2-yl]purin-6-yl]-N,N-dimethyl-acetamidine
Nucleoside phosphoramidite building block
Tert-butyl (5R)-5-amino-3,3-difluoropiperidine-1-carboxylate
pharmaceutical intermediate
Micafungin Impurity H
pharmaceutical impurity reference standard
(2S)-6-amino-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)hexanoic acid hydrochloride
Fmoc-protected lysine for peptide synthesis
Aceclofenac Methyl Ester
Pharmaceutical intermediate for aceclofenac synthesis
5'-O-DMT-N2-DMF-dG
Nucleoside protecting group intermediate
N'-[9-[(2R,3S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-fluorooxolan-2-yl]-6-oxo-1H-purin-2-yl]-N,N-dimethylmethanimidamide
BUKKJOTXODUNQK-NTXSMOKRSA-N
CC(C)N(C(C)C)P(OCCC#N)OC1[C@H](O[C@H]([C@H]1F)N2C=NC3=C2N=C(NC3=O)/N=C/N(C)C)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC
—